Popular TV series may help reduce stigma around Alzheimer’s
By
John Roszkowski
Sep 02, 2022
The narrative and dramatization of Alzheimer’s disease in the popular TV series “This is Us” may help reduce the stigma around dementia and promote family discussions about plans for aging, new...
PPIs do not raise dementia risk, review finds
By
Alicia Lasek
Jan 06, 2020
There is no link between a common class of acid reflux medications and increased dementia risk, according to a new analysis.
Clinical Briefs for Friday, May 22
By
Alicia Lasek
May 21, 2020
Infection control problems ‘persisted’ at nursing homes prior to pandemic: GAO … New AARP report spotlights Alzheimer’s toll on women … Emerging medical countermeasures to COVID-19 may be best...
Most elders use sleep meds, but only half discuss use with their doctors: study
By
Amy Novotney
Nov 05, 2021
Older adults frequently use medication to treat sleep difficulties, but only about half discuss it with their physicians, study results presented at Psych Congress 2021 this week found. In fact, the majority...
Vigorous exercise may guard against death from Alzheimer’s disease
By
Kristen Fischer
Dec 18, 2023
Engaging in vigorous activity compared to moderate exercise may lower the rate of dying from Alzheimer’s disease, according to a new study. The study was published in the December issue of The Lancet...
Mid-life racial discrimination in Black Americans tied to Alzheimer’s later on, study finds
By
Kristen Fischer
Apr 12, 2024
Racial discrimination during midlife is linked to Alzheimer’s disease, a new study finds.
Older adults who volunteered more often had better emotional well-being, were less likely to have Alzheimer’s disease and had lower risks for not being able to perform activities of daily living.
Vascular risk factors raise odds of Alzheimer’s disease in Blacks, Hispanics: study
By
Alicia Lasek
Jan 05, 2023
Vascular risk helps to explain the outsized odds of Alzheimer’s faced by African Americans and Hispanics in the United States, a new study has found.
Medicare costs could rise by $5B annually with expanded Alzheimer’s drug coverage: study
By
Alicia Lasek
May 12, 2023
Medicare costs could rise by $2 to $5 billion a year if CMS expands its coverage for newly approved Alzheimer’s disease drug Leqembi (lecanemab), investigators say.
Scent waning? This Alzheimer’s gene may be the culprit, study shows
By
Kristen Fischer
Jul 27, 2023
Sense of smell may be the first to go in people who carry a gene variant that’s linked to the highest risk for Alzheimer’s disease, according to a new study.